Abstract:Background and aims: Breast milk jaundice (BMJ) is common and benign, but neonatal cholestasis (NC) is rare and not benign, so early differentiation between NC and non-NC jaundice is important and may facilitate diagnosis and treatment. Gut microbiota plays an important role in enterohepatic circulation, which in turn plays an important role in the secretion of bilirubin. We aimed to determine the composition of gut microbiota in patients with NC and BMJ, and to identify the gut microbiota composition associated with NC and BMJ. Methods: Data on age, gender, delivery, feeding mode, serum total bilirubin, direct bilirubin, and liver function were collected for NC patients, BMJ patients and healthy controls, respectively. Shotgun metagenomic sequencing and metagenome-wide association were performed. Results: Forty NC patients, 16 patients affected by BMJ, and 14 healthy controls (CON) without jaundice were enrolled. A significant increase in species richness, especially Bacteroides, was found in NC patients. The abundances of potentially pathogenic species and KEGG orthologies (KOs) of virulence factor genes were positively correlated with serum bilirubin level. The abundances of nine species of Bifidobacterium and three KOs of galactose metabolism were significantly decreased in the jaundice group (NC and BMJ) and were negatively correlated with serum bilirubin level. Conclusions: The gut microbiota in NC patients is characterized by a significant increase in species richness, possibly due to the proliferation of potentially pathogenic species. Additionally, the gut microbiota in jaundice patients is characterized by a decreased abundance of Bifidobacterium. Decreased Bifidobacterium has been associated with elevated bilirubin and abnormal gut microbiota galactose metabolic pathway. Further, ten bacteria species were identified as potential biomarker of jaundice. Key points: Question Is there any alteration of gut microbiotain neonatal cholestasis patients? Does gut microbiota have any involvement in the occurrence of neonatal cholestasis or breast milk jaundice? Findings The alteration of gut microbiota in neonatal cholestasis patients mainly manifested as a significant increase in species richness and an increased abundance of potentially pathogenic species, while the main manifestation in jaundice patients was a significant decrease in Bifidobacterium which may be involved in the metabolism of bilirubin through the galactose metabolic pathway. Meaning The results suggest that an imbalance of gut microbiota exist in neonatal cholestasis and breast milk jaundice patients, primarily in the form of a substantial reduction in the abundance of Bifidobacterium, suggesting the possibility of intervention treatment for neonatal cholestasis and breast milk jaundice by supplementing probiotics. (C) 2018 Elsevier Inc. All rights reserved.

The Role of Microbiota in Neonatal Hyperbilirubinemia

Neonatal hyperbilirubinemia management: Clinical assessment of bilirubin production.

The Role of Microbiota in Infant Health: from Early Life to Adulthood

Neuroinflammation in Bilirubin Neurotoxicity.

Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels.

Research Progress of Bilirubin-Induced Brain Injury in Preterm Neonate

What Happens in the Gut during the Formation of Neonatal Jaundice-Underhand Manipulation of Gut Microbiota?

Clinical Manifestations of Neonatal Hyperbilirubinemia Are Related to Alterations in the Gut Microbiota

Advances in Treatment of Neonatal Hyperbilirubinemia

Analysis of High Risk Factors in 210 Neonates with Hyperbilirubinemia

Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemia

Association of Serum Bilirubin in Newborns Affected by Jaundice with Gut Microbiota Dysbiosis.

Integrated Analysis of Microbiota with Bile Acids for the Phototherapy Treatment of Neonatal Jaundice

Microbiome-targeting therapies in the neonatal intensive care unit: safety and efficacy

Changes in Intestinal Flora and Metabolites in Neonates with Breast Milk Jaundice

Gut Microbial Variation May Predict Neonatal Jaundice and Microbial Alterations After Treatment

Progress of neonatal severe hyperbilirubinemia therapies

Clinical analysis of 1 082 cases of neonatal hyperbilirubinemia

Neonatal microbiota-epithelial interactions that impact infection

Research progress about neonatal hyperbilirubinemia and cytokines

Clinical and genetic risk factors associated with neonatal severe hyperbilirubinemia: a case–control study based on the China Neonatal Genomes Project